联合门静脉切除的肝门部胆管癌根治切除术  

Portal vein excision in radical resection of hilar cholangiocarcinoma

作　　者：王建立[1] 李森[2] 冯立民[1] 徐克森[1] 董典宁[1] 宋钦华[2] 寿楠海[1] 

机构地区：[1]山东大学齐鲁医院普外科,济南市250012 [2]山东潍坊市人民医院肝胆外科

出　　处：《中华肝胆外科杂志》2005年第3期167-168,共2页Chinese Journal of Hepatobiliary Surgery

摘　　要：目的　观察联合门静脉切除在肝门部胆管癌治疗中的作用,以进一步提高肝门胆管癌的治疗效果。方法　总结1990年3 月至2002 年3 月我院收治的78 例肝门部胆管癌的临床资料。结果　本组联合门静脉切除12例,其中门静脉分叉部联合左半肝切除3例,门静脉主干切除6例,门静脉侧壁切除修补术3例;术后肝肠吻合口漏、肝功能衰竭死亡1例;其余11例病人术后随访6 个月至6年,平均19个月,其中最长的1例已存活6年。结论　联合门静脉切除可提高肝门部胆管癌的治愈切除率,改善术后病人预后。Objective To investigate the role of portal vein excision in radical resection of hilar cholangiocarcinoma and to improve the therapeutic efficacy. Methods The clinical data of 78 patients with hilar cholangiocarcinoma surgically treated in our hospital from 1990 to 2002 were retrospectively analyzed. Results Of these 78 patients, 12 received resection of hilar cholangiocarcinoma in combination with portal vein excision. Among the 12 patients, 3 underwent resection of furcation of the portal vein and left liver, 6 portal vein resection and 3 resection of part of the lateral wall of the portal vein. One patient died of leakage at the anastomosis and hepatic functional failure and the other 11 were followed up for 6 month to 6 years (mean=19 months). One patient survived for more than 6 years. Conclusions The combination of the portal vein excision may raise the radical resection rate of hilar cholangiocarcinoma and improve the prognosis after operation.

关 键 词：门静脉 联合 肝门部胆管癌 根治切除术 切除率 治疗中 吻合 存活 肝切除 

分 类 号：R735.8[医药卫生—肿瘤] R657[医药卫生—临床医学]